Last edition
News about Drug Discovery & Development
Pfizer and Innovent Biologics Partner to Advance Global Oncology Drug Development
Pfizer and Innovent Biologics have entered a global strategic collaboration to develop innovative oncology medicines, combining 12 discovery and early-stage programs to accelerate cancer drug development through shared research, clinical development, and commercialisation efforts.
Drug Discovery & Development | 29/05/2026 | By News Bureau
The Lupus Research Alliance and Genentech announce inaugural recipients of the Immune Resetting Therapies for Lupus Award to accelerate research into CAR-T cell therapies for severe lupus patients.
Drug Discovery & Development | 28/05/2026 | By News Bureau
Merz Therapeutics and Kvvit Sign China Deal for INBRIJA Parkinson's Therapy
Merz Therapeutics and Kvvit sign an exclusive agreement for commercialization of INBRIJA in mainland China, Hong Kong, and Macao, expanding access to advanced treatment options for Parkinson's disease patients.
Drug Discovery & Development | 26/05/2026 | By News Bureau | 125
Ichnos Glenmark Innovation Unveils Novel Multispecific Antibody Candidate for Solid Tumour Treatment
Ichnos Glenmark Innovation has introduced ISB 2301, a next-generation multispecific antibody designed to activate immune cells and target solid tumours through a multi-mechanism approach aimed at improving cancer treatment outcomes.
Drug Discovery & Development | 22/05/2026 | By News Bureau | 119
RFiD Discovery Deploys RFID Inventory Tracking System for Sanofi R&D Sites
RFiD Discovery has implemented a passive RFID inventory management system for Sanofi, enabling real-time tracking of critical research materials at its R&D facilities in France and the United States.
Drug Discovery & Development | 18/05/2026 | By News Bureau | 109
Researchers Discover First Human Antibody Panel Targeting Measles Virus
NIH-funded researchers identify the first suite of human antibodies targeting the measles virus, paving the way for new antibody-based treatments.
Drug Discovery & Development | 16/05/2026 | By News Bureau | 107
VoxCell BioInnovation and adMare BioInnovations have launched a research partnership focused on validating antibody-based cancer therapies using advanced bioprinted human tissue models designed to improve predictive drug testing and accelerate oncology innovation.
Drug Discovery & Development | 15/05/2026 | By News Bureau | 105
Fosun Pharma and AriBio Sign Global Deal for AR1001 to Treat Alzheimer's
Fosun Pharma and AriBio signed an exclusive global option agreement for AR1001, an investigational Alzheimer’s disease treatment, with a USD 60 million option fee.
Drug Discovery & Development | 14/05/2026 | By News Bureau | 183
Scientists at The University of Tulsa have developed new memantine-based compounds capable of crossing the blood-brain barrier and demonstrating higher anticancer activity against glioblastoma cells than standard chemotherapy treatments.
Drug Discovery & Development | 12/05/2026 | By News Bureau
Formosa Pharmaceuticals Partners with Singapore Eye Research Institute for Corneal Disease Therapies
Formosa Pharmaceuticals partners with Singapore Eye Research Institute to develop next-generation ophthalmic formulations using APNT nanoparticle technology and advanced clinical research expertise for corneal diseases.
Drug Discovery & Development | 02/05/2026 | By News Bureau | 115
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy